Neurotensin selectively facilitates glutamatergic transmission in globus pallidus

Neuroscience

Volumn 141, Issue 4, 2006, Pages 1871-1878

  Chen, L ^a,b   Yung, K K L ^c   Yung, W H ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b QINGDAO UNIVERSITY   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

globus pallidus; neurotensin; postsynaptic currents

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; 2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; NEUROTENSIN; NEUROTENSIN RECEPTOR ANTAGONIST; NEUROTENSIN[8-13];

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DEPOLARIZATION; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC TRANSMISSION; GLOBUS PALLIDUS; INHIBITORY POSTSYNAPTIC POTENTIAL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE; WHOLE CELL;

ANESTHETICS, LOCAL; ANIMALS; ANIMALS, NEWBORN; BICUCULLINE; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; ELECTRIC STIMULATION; ENZYME INHIBITORS; ESTRENES; EXCITATORY POSTSYNAPTIC POTENTIALS; GABA ANTAGONISTS; GLOBUS PALLIDUS; GLUTAMIC ACID; NEURAL INHIBITION; NEURONS; NEUROTENSIN; PATCH-CLAMP TECHNIQUES; PYRAZOLES; PYRROLIDINONES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION; TETRODOTOXIN;

EID: 33747202699     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.05.049     Document Type: Article

References (34)

1. Antonelli T., Ferraro L., Fuxe K., Finetti S., Fournier J., Tanganelli S., De Mattei M., and Tomasini M.C. Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons. involvement of neurotensin receptor in NMDA induced excitotoxicity. Cereb Cortex 14 (2004) 466-473
2. Atoji Y., Watanabe H., Yamamoto Y., and Suzuki Y. Distribution of neurotensin-containing neurons in the central nervous system of the dog. J Comp Neurol 353 (1995) 67-88
3. Bergman H., Feingold A., Nini A., Raz A., Slovin H., Abeles M., and Vaadia E. Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends Neurosci 21 (1998) 32-38
4. Bissette G., Nemeroff C.B., Decker M.W., Kizer J.S., Agid Y., and Javoy-Agid F. Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's disease. Ann Neurol 17 (1985) 324-328
5. Boules M., Warrington L., Fauq A., McCormick D., and Richelson E. Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats. Eur J Pharmacol 428 (2001) 227-233
6. Carraway R., and Leeman S.E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 248 (1973) 6854-6861
7. Chen L., Yung K.K.L., and Yung W.H. Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor. Neuroscience 125 (2004) 853-859
8. Chinaglia G., Probst A., and Palacios J.M. Neurotensin receptors in Parkinson's disease and progressive supranuclear palsy. an autoradiographic study in basal ganglia. Neuroscience 39 (1990) 351-360
9. El-Deredy W., Branston N.M., Samuel M., Schrag A., Rothwell J.C., Thomas D.G., and Quinn N.P. Firing patterns of pallidal cells in parkinsonian patients correlate with their pre-pallidotomy clinical scores. Neuroreport 11 (2000) 3413-3418
10. Faggin B.M., Zubieta J.K., Rezvani A.H., and Cubeddu L.X. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate. J Pharmacol Exp Ther 252 (1990) 817-825
11. Fassio A., Evans G., Grisshammer R., Bolam J.P., Mimmack M., and Emson P.C. Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody. Neuropharmacology 39 (2000) 1430-1142
12. Fernandez A., de Ceballos M.L., Jenner P., and Marsden C.D. Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients. Neuroscience 61 (1994) 73-79
13. Ferraro L., Antonelli T., O'Connor W.T., Fuxe K., Soubrie P., and Tanganelli S. The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release. functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop. J Neurosci 18 (1998) 6977-6989
14. Ferraro L., Tanganelli S., O'Connor W.T., Bianchi C., Ungerstedt U., and Fuxe K. Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat. Synapse 20 (1995) 362-364
15. Ferraro L., Tomasini M.C., Fernandez M., Bebe B.W., O'Connor W.T., Fuxe K., Glennon J.C., Tanganelli S., and Antonelli T. Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission. a dual-probe microdialysis study in intact conscious rat brain. Neuroscience 102 (2001) 113-120
16. Ferraro L., Tomasini M.C., Siniscalchi A., Fuxe K., Tanganelli S., and Antonelli T. Neurotensin increases endogenous glutamate release in rat cortical slices. Life Sci 66 (2000) 927-936
17. Garver D.L., Bissette G., Yao J.K., and Nemeroff C.B. Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients. Am J Psychiatry 148 (1991) 484-488
18. Kasckow J., and Nemeroff C.B. The neurobiology of neurotensin. focus on neurotensin-dopamine interactions. Regul Pept 36 (1991) 153-164
19. Kinkead B., and Nemeroff C.B. Neurotensin, schizophrenia, and antipsychotic drug action. Int Rev Neurobiol 59 (2004) 327-349
20. Magill P.J., Bolam J.P., and Bevan M.D. Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience 106 (2001) 313-330
21. Martorana A., Fusco F.R., D'Angelo V., Sancesario G., and Bernardi G. Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra. Exp Neurol 183 (2003) 311-319
22. McCormick S.E., and Stoessl A.J. Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia. Neuroscience 119 (2003) 547-555
23. Meyer-Spasche A., Reed H.E., and Piggins H.D. Neurotensin phase-shifts the firing rate rhythm of neurons in the rat suprachiasmatic nuclei in vitro. Eur J Neurosci 16 (2002) 339-344
24. Ogawa W.N., Baptista V., Aguiar J.F., and Varanda W.A. Neurotensin modulates synaptic transmission in the nucleus of the solitary tract of the rat. Neuroscience 130 (2005) 309-315
25. Plenz D., and Kital S.T. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 400 (1999) 677-682
26. Saleh T.M., Kombian S.B., Zidichouski J.A., and Pittman Q.J. Cholecystokinin and neurotensin inversely modulate excitatory synaptic transmission in the parabrachial nucleus in vitro. Neuroscience 77 (1997) 23-35
27. Sanz B., Exposito I., and Mora F. Effects of neurotensin on the release of glutamic acid in the prefrontal cortex and striatum of the rat. Neuroreport 4 (1993) 1194-1196
28. Sarret P., Perron A., Stroh T., and Beaudet A. Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system. J Comp Neurol 461 (2003) 520-538
29. Tanji H., Araki T., Fujihara K., Nagasawa H., and Itoyama Y. Alteration of neurotensin receptors in MPTP-treated mice. Peptides 20 (1999) 803-807
30. Trudeau L.E. Neurotensin regulates intracellular calcium in ventral tegmental area astrocytes. evidence for the involvement of multiple receptors. Neuroscience 97 (2000) 293-302
31. Vincent J.P., Mazella J., and Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol Sci 20 (1999) 302-309
32. Wang R., Boules M., Tiner W., and Richelson E. Effects of repeated injections of the neurotensin analog NT69L on dopamine release and uptake in rat striatum in vitro. Brain Res 1025 (2004) 21-28
33. Yamada M., Yamada M., and Richelson E. Heterogeneity of melanized neurons expressing neurotensin receptor messenger RNA in the substantia nigra and the nucleus paranigralis of control and Parkinson's disease brain. Neuroscience 64 (1995) 405-417
34. Zahm D.S., and Heimer L. Ventral striatopallidal parts of the basal ganglia in the rat: I. Neurochemical compartmentation as reflected by the distributions of neurotensin and substance P immunoreactivity. J Comp Neurol 272 (1988) 516-535